Article History
Received: 9 November 2020
Accepted: 30 November 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: R.F. is a lead investigator for Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial (CATCO). J.T., R.F., and A.B. are site investigators for CATCO and REMAP-CAP (Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia). A.B. is also a site investigator for the RAPID study (Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care). The authors have received research funding from the Canadian Institutes of Health Research (R.F., J.T., A.B.), Mohawk MedBuy non-profit (J.T., A.B.), and Canadian Critical Care Trials Group (J.T., A.B.).
Free to read: This content has been made available to all.